open access

Vol 69, Supp. I (2011)
Original articles
Published online: 2011-11-25
Submitted: 2012-12-28
Get Citation

Current status of drug-eluting stents and drug-eluting balloons in patients with stable coronary artery disease — an expert consensus document of the Association for Percutaneous Cardiovascular Interventions and Polish Cardiac Society

Adam Witkowski, Maksymilian P. Opolski, Dariusz Dudek, Maciej Lesiak, Jacek Legutko, Wojciech Wojakowski, Andrzej Ochała, Paweł Maciejewski, Tomasz Deptuch, Aleksander Araszkiewicz, Dariusz Ciećwierz; Recenzenci z ramienia Gil, Stefan Grajek, Lech Poloński

open access

Vol 69, Supp. I (2011)
Original articles
Published online: 2011-11-25
Submitted: 2012-12-28

Abstract

Despite a dramatic reduction in restenosis and target vessel revascularisation rates by drug eluting stents (DES), conflicting concerns have been raised over the risk for late DES thrombosis when compared to bare metal stents. Certainly, the heterogeneity of DES results from the introduction of a great variety of new DES types with diverse efficacy and safety parameters. Furthemore, we observe a steady increase in DES availability without parallel and robust data from randomised clinical trials. Thus, the postulated class effect of DES should be regarded as nonobligatory. This article is based on 110 randomised DES trials performed on 72 305 patients. Current status of DES and guidelines for DES implantation in various clinical scenarios were discussed.
Kardiol Pol 2011; 69, supl. I: 1–36

Abstract

Despite a dramatic reduction in restenosis and target vessel revascularisation rates by drug eluting stents (DES), conflicting concerns have been raised over the risk for late DES thrombosis when compared to bare metal stents. Certainly, the heterogeneity of DES results from the introduction of a great variety of new DES types with diverse efficacy and safety parameters. Furthemore, we observe a steady increase in DES availability without parallel and robust data from randomised clinical trials. Thus, the postulated class effect of DES should be regarded as nonobligatory. This article is based on 110 randomised DES trials performed on 72 305 patients. Current status of DES and guidelines for DES implantation in various clinical scenarios were discussed.
Kardiol Pol 2011; 69, supl. I: 1–36
Get Citation

Keywords

drug eluting stents; drug eluting balloons; randomised clinical trials

About this article
Title

Current status of drug-eluting stents and drug-eluting balloons in patients with stable coronary artery disease — an expert consensus document of the Association for Percutaneous Cardiovascular Interventions and Polish Cardiac Society

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 69, Supp. I (2011)

Pages

1-38

Published online

2011-11-25

Keywords

drug eluting stents
drug eluting balloons
randomised clinical trials

Authors

Adam Witkowski
Maksymilian P. Opolski
Dariusz Dudek
Maciej Lesiak
Jacek Legutko
Wojciech Wojakowski
Andrzej Ochała
Paweł Maciejewski
Tomasz Deptuch
Aleksander Araszkiewicz
Dariusz Ciećwierz; Recenzenci z ramienia Gil
Stefan Grajek
Lech Poloński

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl